Should alpha interferon be prescribed at a dose depending on body surface area for the treatment of chronic hepatitis C ?

1994 ◽  
Vol 21 ◽  
pp. S39
2002 ◽  
Vol 76 (16) ◽  
pp. 8189-8199 ◽  
Author(s):  
Valérie Castet ◽  
Chantal Fournier ◽  
Alexandre Soulier ◽  
Rozenn Brillet ◽  
Joliette Coste ◽  
...  

ABSTRACT Chronic hepatitis C is a common cause of liver disease, the complications of which include cirrhosis and hepatocellular carcinoma. Treatment of chronic hepatitis C is based on the use of alpha interferon (IFN-α). Recently, indirect evidence based on mathematical modeling of hepatitis C virus (HCV) dynamics during human IFN-α therapy suggested that the major initial effect of IFN-α is to block HCV virion production or release. Here, we used primary cultures of healthy, uninfected human hepatocytes to show that: (i) healthy human hepatocytes can be infected in vitro and support HCV genome replication, (ii) hepatocyte treatment with IFN-α results in expression of IFN-α-induced genes, and (iii) IFN-α inhibits HCV replication in infected human hepatocytes. These results show that IFN-α acts primarily through its nonspecific antiviral effects and suggest that primary cultures of human hepatocytes may provide a good model to study intrinsic HCV resistance to IFN-α.


Gut ◽  
1992 ◽  
Vol 33 (6) ◽  
pp. 855-856 ◽  
Author(s):  
P Marcellin ◽  
M Pouteau ◽  
P Renard ◽  
J M Grynblat ◽  
N Colas Linhart ◽  
...  

Haemophilia ◽  
1995 ◽  
Vol 1 (1) ◽  
pp. 45-53 ◽  
Author(s):  
E. P. Mauser-Bunschoten ◽  
D. Bresters ◽  
H. W. Reesink ◽  
G. Roosendaal ◽  
R. A. F. M. Chamuleau ◽  
...  

2000 ◽  
Vol 20 (3) ◽  
pp. 234-239 ◽  
Author(s):  
Marta Wawrzynowicz-Syczewska ◽  
James A. Underhill ◽  
Michael A. Clare ◽  
Anna Boron-Kaczmarska ◽  
Ian G. McFarlane ◽  
...  

2001 ◽  
Vol 15 (5) ◽  
pp. 333-335 ◽  
Author(s):  
Ivan Kraus ◽  
Dinko Vitezic

Hepatic adverse effects occur very rarely with alpha-interferon therapy. A case of acute hepatitis induced by alpha-interferon in a 33-year-old man with chronic hepatitis C is described. The patient developed acute hepatitis with very high aminotransferase activity and jaundice. After discontinuing alpha-interferon therapy, hepatitis resolved rapidly. The immune-mediated mechanism is the most probable cause of this hepatitis.


1993 ◽  
Vol 28 (S5) ◽  
pp. 109-114 ◽  
Author(s):  
M. Yoshikawa ◽  
T. Sakamoto ◽  
A. MitorO ◽  
T. Mochi ◽  
H. Tsujii ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document